KRAS (Kirsten Rat Sarcoma virus) is the most important oncogene in pancreatic, colon, and lung cancer that quite recently can be targeted by inhibitors that covalently bind to the KRAS G12C mutant [1]. Here, KRAS is linked to lung cancer.